Urticaria | Platelet Activation in Chronic Inflammatory Skin Diseases

Urticaria research study

What is the primary objective of this study?

Platelets are blood cells that are important in coagulation of the blood. These cells have recently been shown to play a role in a number of other biologic processes, for example inflammation. In this study the investigators will determine the extent of platelet activation in people suffering from common chronic skin inflammation-urticaria and allergic dermatitis.

Who is eligible to participate?

Inclusion Criteria: Urticaria or atopic dermatitis - Exclusion Criteria:Lack of informed consent

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?


Atopic Dermatitis

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Procedure:Blood samplingBlood sampling

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Skin diseasePatients with urticaria or atopic dermatitis

ControlHealthy volunteers

Study Status

Unknown status

Start Date: February 2013

Completed Date: October 2013


Type: Observational


Primary Outcome: Platelet activation

Secondary Outcome: Mean platelet volume

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: Meir Medical Center


More information:

Discuss Urticaria